[COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients].
作者信息
Richier Q, Hueso T, Tiberghien P, Lacombe K
机构信息
Sorbonne université, Paris, France; Service de maladies infectieuses, hôpital Saint-Antoine, AP-HP, 75012 Paris, France.
Service d'hématologie clinique, hôpital Avicenne, Sorbonne université Paris-Nord, AP-HP, Bobigny, France.
出版信息
Rev Med Interne. 2023 Sep;44(9):467-471. doi: 10.1016/j.revmed.2023.08.005. Epub 2023 Sep 7.
PMID:37689526
Abstract
摘要
相似文献
1
[COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients].[新型冠状病毒肺炎：恢复期血浆疗法仍有应用空间？聚焦免疫功能低下患者]
Rev Med Interne. 2023 Sep;44(9):467-471. doi: 10.1016/j.revmed.2023.08.005. Epub 2023 Sep 7.
2
Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations.恢复期血浆在免疫功能低下和脆弱人群中预防和治疗 SARS-CoV-2 的潜在用途。
Expert Rev Vaccines. 2022 Jul;21(7):877-884. doi: 10.1080/14760584.2021.1932475. Epub 2021 May 27.
3
Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19.免疫抑制患者 COVID-19 的门诊治疗与疫苗加强恢复期血浆治疗。
mBio. 2024 May 8;15(5):e0040024. doi: 10.1128/mbio.00400-24. Epub 2024 Apr 11.
4
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.免疫功能低下宿主接受恢复期血浆治疗后出现多种 SARS-CoV-2 抗体逃逸变异体。
mSphere. 2021 Aug 25;6(4):e0048021. doi: 10.1128/mSphere.00480-21.
5
Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS-CoV-2.免疫功能低下的奥密克戎 BA.1 或 BA.2 感染患者的恢复期血浆治疗。
Influenza Other Respir Viruses. 2024 Mar;18(3):e13272. doi: 10.1111/irv.13272.
6
Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection.两名免疫功能低下的持续性 COVID-19 感染者在抗体治疗后出现刺突突变的演变。
J Med Virol. 2022 Mar;94(3):1241-1245. doi: 10.1002/jmv.27445. Epub 2021 Nov 13.
7
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients.关于使用新冠康复者血浆治疗免疫功能低下患者的建议。
Semin Thromb Hemost. 2024 Jun;50(4):648-653. doi: 10.1055/s-0043-1776876. Epub 2023 Nov 20.
8
Treatment of immunocompromised COVID-19 patients with convalescent plasma.免疫抑制的 COVID-19 患者使用恢复期血浆治疗。
Transpl Infect Dis. 2021 Apr;23(2):e13477. doi: 10.1111/tid.13477. Epub 2020 Nov 29.
9
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.在血液系统恶性肿瘤患者中使用恢复期/疫苗接种后血浆治疗慢性 COVID-19。
Int J Cancer. 2024 Aug 15;155(4):618-626. doi: 10.1002/ijc.34988. Epub 2024 May 9.
10
Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy.了解指导使用新冠康复期血浆疗法治疗B细胞耗竭患者的最佳实践参数。
Br J Haematol. 2023 Jan;200(2):e25-e27. doi: 10.1111/bjh.18540. Epub 2022 Nov 10.
Zotero 插件